Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06852222. IPD Sharing: YES. Countries: 24. Publications: 0.
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06802315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05947344. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02181699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT00957385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07008638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04777916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
ClinicalTrials.gov study NCT04827069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00129948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00322673. IPD Sharing: Not stated. Countries: 1. Publications: 0.
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02283190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01041040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD)
ClinicalTrials.gov study NCT03699384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04826523. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
ClinicalTrials.gov study NCT01819792. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04443751. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT06317649. IPD Sharing: YES. Countries: 2. Publications: 0.
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05000801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
ClinicalTrials.gov study NCT01770158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04373395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.